| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.25 |
3e-06 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.2 |
0.0001 |
| mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.41 |
0.0002 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
| mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.001 |